Literature DB >> 26511651

Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.

Stylianos Ravanidis1, Kyriaki Nepheli Poulatsidou1, Roza Lagoudaki1, Olga Touloumi1, Elena Polyzoidou1, Athanasios Lourbopoulos1, Evangelia Nousiopoulou1, Paschalis Theotokis1, Evangelia Kesidou1, Dimitrios Tsalikakis1, Dimitrios Karacostas1, Maria Grigoriou2, Katerina Chlichlia2, Nikolaos Grigoriadis3.   

Abstract

UNLABELLED: Neural precursor cell (NPC) transplantation has been proposed as a therapy for multiple sclerosis (MS) and other degenerative disorders of the central nervous system (CNS). NPCs are suggested to exert immune modulation when they are transplanted in the animal model of MS, experimental autoimmune encephalomyelitis (EAE). Herein, we explore whether the effect of NPC transplantation on the clinical course and the pathological features of EAE is combined with the modulation of chemokines levels expressed in the inflamed CNS. NPCs were isolated from brains of neonatal C57/Bl6 mice and were subcutaneously administered in female mice with myelin oligodendrocyte glycoprotein (MOG)-induced EAE. Clinical signs of the disease and transcript analysis of the CNS in the acute phase were performed. In addition, the presence of inflammatory components in the spinal cord was evaluated and ex vivo proliferation of lymphocytes was measured. NPC recipients exhibited ameliorated clinical outcome and less pronounced pathological features in their spinal cord. Downregulation of chemokine mRNA levels throughout the CNS was correlated with diminished Mac-3-, CD3-, and CD4-positive cells and reduced expression levels of antigen-presenting molecules in the spinal cord. Moreover, NPC transplantation resulted in lymphocyte-related, although not splenocyte-related, peripheral immunosuppression. We conclude that NPCs ameliorated EAE potentially by modulating the levels of chemokines expressed in the inflamed CNS, thus resulting in the impaired recruitment of immune cells. These findings further contribute to the better understanding of NPCs' immunomodulatory properties in neuroinflammatory disorders, and may lead to faster translation into potential clinical use. SIGNIFICANCE: Endogenous neural precursor cells of the central nervous system are able to migrate and differentiate toward mature cells to repair an injury. There is increasing evidence that autologous transplantation of these cells in experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis, may have a beneficial effect on the disease process. Several mechanisms have been proposed-among them, the potentiation of endogenous precursor cell differentiation of the central nervous system and the modulation of demyelinating and neurodegenerative immune-mediated processes. This article provides evidence of interference in immune signaling within the central nervous system as a potential mechanism underlying the immunomodulatory properties of transplanted neural precursor cells. ©AlphaMed Press.

Entities:  

Keywords:  Chemokines; Experimental autoimmune encephalomyelitis; Immunomodulation; Multiple sclerosis; Neural precursor cells

Mesh:

Year:  2015        PMID: 26511651      PMCID: PMC4675506          DOI: 10.5966/sctm.2015-0068

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  65 in total

Review 1.  CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

Authors:  Paul Andrew Antony; Nicholas P Restifo
Journal:  J Immunother       Date:  2005 Mar-Apr       Impact factor: 4.456

2.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

Authors:  Stefano Pluchino; Lucia Zanotti; Barbara Rossi; Elena Brambilla; Linda Ottoboni; Giuliana Salani; Marianna Martinello; Alessandro Cattalini; Alessandra Bergami; Roberto Furlan; Giancarlo Comi; Gabriela Constantin; Gianvito Martino
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

3.  Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway.

Authors:  Jaime Imitola; Khadir Raddassi; Kook In Park; Franz-Josef Mueller; Marta Nieto; Yang D Teng; Dan Frenkel; Jianxue Li; Richard L Sidman; Christopher A Walsh; Evan Y Snyder; Samia J Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

Review 4.  Neural stem cells and their use as therapeutic tool in neurological disorders.

Authors:  Stefano Pluchino; Lucia Zanotti; Michela Deleidi; Gianvito Martino
Journal:  Brain Res Brain Res Rev       Date:  2005-01-20

5.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

6.  A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors.

Authors:  M Dziembowska; T N Tham; P Lau; S Vitry; F Lazarini; M Dubois-Dalcq
Journal:  Glia       Date:  2005-05       Impact factor: 7.452

7.  Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.

Authors:  Sawako Kato; Yukio Yuzawa; Naotake Tsuboi; Shoichi Maruyama; Yoshiki Morita; Tetsuya Matsuguchi; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

8.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  Time course and spatial profile of Nogo-A expression in experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Paschalis Theotokis; Athanasios Lourbopoulos; Olga Touloumi; Roza Lagoudaki; Evangelia Kofidou; Evangelia Nousiopoulou; Kyriaki-Nepheli Poulatsidou; Evangelia Kesidou; Nikolaos Tascos; Evangelia Spandou; Nikolaos Grigoriadis
Journal:  J Neuropathol Exp Neurol       Date:  2012-10       Impact factor: 3.685

10.  Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.

Authors:  Lisa C Parker; Moira K B Whyte; Stefanie N Vogel; Steven K Dower; Ian Sabroe
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

View more
  4 in total

Review 1.  Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Yunhua Zhu; Xin Qin; Min Zhang; Lihong Zhai; Yi Luo; Xiaoming He; Chun Mao; Wenbin Deng
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

Review 2.  Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Elham Nikzad
Journal:  Cell J       Date:  2016-12-21       Impact factor: 2.479

3.  Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells.

Authors:  Stylianos Ravanidis; Jeroen F J Bogie; Raf Donders; Robert Deans; Jerome J A Hendriks; Piet Stinissen; Jef Pinxteren; Robert W Mays; Niels Hellings
Journal:  Stem Cells Int       Date:  2017-07-12       Impact factor: 5.443

Review 4.  The Molecular Basis for Remyelination Failure in Multiple Sclerosis.

Authors:  Joel Gruchot; Vivien Weyers; Peter Göttle; Moritz Förster; Hans-Peter Hartung; Patrick Küry; David Kremer
Journal:  Cells       Date:  2019-08-03       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.